Comparing the clinicopathological characteristics of combined hepatocellular–cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classification-Reference-Cited by-同舟云学术

Comparing the clinicopathological characteristics of combined hepatocellular–cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classification

Published:2021-06-23 Issue:4 Volume:79 Page:556-572
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Yen Chih‐Chieh¹²^ORCID,Yen Chia‐Jui³,Shan Yan‐Shen⁴,Lin Yih‐Jyh⁴,Liu I‐Ting²³,Huang Hsuan‐Yi⁵,Yeh Matthew M⁶⁷,Chan Shih‐Huang⁸,Tsai Hung‐Wen⁹

Affiliation:

1. Division of Haematology/Oncology Department of Internal Medicine National Cheng Kung University Hospital DouLiuo Branch YunlinTaiwan

2. Institute of Clinical Medicine College of Medicine National Cheng Kung University Hospital National Cheng Kung University TainanTaiwan

3. Department of Oncology College of Medicine National Cheng Kung University Hospital National Cheng Kung University TainanTaiwan

4. Department of Surgery College of Medicine National Cheng Kung University Hospital National Cheng Kung University TainanTaiwan

5. Division of Colorectal Surgery Department of Surgery Chi Mei Medical Centre Tainan Taiwan

6. Department of Laboratory Medicine and Pathology University of Washington School of Medicine Seattle WAUSA

7. Department of Medicine University of Washington School of Medicine Seattle WA USA

8. Department of Statistics College of Management National Cheng Kung University TainanTaiwan

9. Department of Pathology College of Medicine National Cheng Kung University Hospital National Cheng Kung University Tainan Taiwan

Funder

National Cheng Kung University Hospital

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.14384

Reference44 articles.

1. Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

2. Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma: A Western Experience

3. Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma

4. Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions

5. Update on hepatocellular carcinoma: Pathologists’ review

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CMTM6 promotes hepatocellular carcinoma invasion and metastasis and tumor-associated neutrophil immunoinfiltration through the Wnt/β-catenin pathway;2024-08-15

2. Case report: Remarkable response to sintilimab, lenvatinib, and nab-paclitaxel in postoperative metastatic chemotherapy-resistant combined hepatocellular-cholangiocarcinoma;Frontiers in Pharmacology;2023-10-13

3. Clinical Characterization of HCC/CCA Mixed Cancers in a Population-based Cohort;Journal of Gastrointestinal and Liver Diseases;2023-06-22

4. Combining Preoperative Clinical and Imaging Characteristics to Predict MVI in Hepatitis B Virus-Related Combined Hepatocellular Carcinoma and Cholangiocarcinoma;Journal of Personalized Medicine;2023-01-29

5. Cmtm6 Promotes Hepatocellular Carcinoma Invasion and Metastasis and Tumor-Associated Neutrophil Immunoinfiltration Through the Wnt/Β-Catenin Signaling Pathway;2023